Abstract
Noninvasive Arrhythmia Risk Assessment in Guiding Pharmacologic Therapy for Prevention of Sudden Cardiac Death: Where Do We Stand? Where Do We Go?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have